Moody’s Investors Service Has Affirmed Its Baa1 Revenue Bond Rating With A Positive Outlook For Ballad Health. This Follows Ballad Health’s A- Credit Rating By Standard And Poor’s In November Of Last Year. Ballad’s Second Quarter Results That Were Released Earlier This Week, Showed Increased Access To New Providers, Cost Savings For Patients, Taxpayers And Employers And Continued Stable Financial Performance In The Face Of Significant Challenges.